Christopher Gibbons

Company: CND Life Sciences
Job title: Chief Scientific Officer & Co-Founder
Seminars:
Optimizing Clinical Trials with Cutaneous Biomarkers in Neurodegenerative Diseases 12:00 pm
Use of Syn-One Biomarker Technology to support study subject homogeneity, identify target engagement, and measure P-SYN deposition changes over time Detection, visualization, and quantification of cutaneous misfolded alpha-synuclein Highlight preliminary data and topline results in current trialsRead more
day: Conference Day One - Track Three